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ABSTRACT
The literature indicates that, in addition to anti-bacterial effects, certain macrolide antibiotics, such as 
azithromycin and clarithromycin, also exert anti-infl ammatory and immunomodulatory activity, by accumulating 
in infl ammatory cells and inhibiting the secretion of pro-infl ammatory cytokines. Previous reports have shown 
that pre-treatment with these macrolides attenuates induced immediate skin infl ammatory reactions in mice. 
However, the anti-infl ammatory activity of the post-infl ammatory induction of macrolide antibiotics in this 
experimental model has not been investigated. The aim of this study was to explore whether the anti-infl ammatory 
activity of azithromycin and clarithromycin, applied transdermally, 30 min after a phorbol 12-myristate 13-
acetate (PMA)-induced immediate skin infl ammation in mice, could attenuate a Th1 infl ammatory reaction. The 
capacity of azithromycin and clarithromycin (500 μg/ear) to exert anti-infl ammatory effects, similar to those of 
dexamethasone (50 μg/ear), was confi rmed by the inhibition by all three agents of ear swelling and interleukin-
1β concentration in the ear tissue of PMA-treated mice, supporting this clinically relevant treatment mode.
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Introduction
Macrolide antibiotics are a commonly used class of antimicrobial agents, isolated 
from Streptomycetes, and have been used for decades in the treatment of moderate to 
severe bacterial infections (ZHANEL et al., 2001). Published results from in vitro and in vivo 
experiments demonstrate that, in addition to their antibacterial effects, certain macrolide 
antibiotics also exert anti-infl ammatory and immunomodulatory activity (CAREVIĆ and 
DJOKIĆ, 1988; ČULIĆ et al., 2001; IVETIĆ TKALČEVIĆ et al., 2006; 2008; BOSNAR et al., 
2009). These macrolides accumulate in infl ammatory cells, especially neutrophils and 
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macrophages (GLADUE et al., 1989; WILDFEUER et al., 1996), inhibiting the synthesis of 
reactive oxygen species and the secretion of cytokines and chemokines (KHAN et al., 1999; 
IANARO et al., 2000; TERAO et al., 2003). 
At the moment, corticosteroids are very frequently used as anti-infl ammatory 
substances for chronic infl ammatory conditions, since they display excellent anti-
infl ammatory activity. However, the side effects observed, such as metabolic disorders, 
increased susceptibility to infection, myopathy, ecchymosis, behavioral disturbances 
and skin atrophy (SCHACKE et al., 2002), following long-term treatment, restricts the 
application of corticosteroids in chronic infl ammatory disorders. Therefore, different 
chemical entities with anti-infl ammatory effects, such as macrolides, are being extensively 
investigated.
A recently published report on the molecular and cellular mechanism of infl ammatory 
reaction in phorbol 12-myristate 13-acetate (PMA) induced skin infl ammation, showed that 
topically applied PMA triggers Th1-mediated infl ammatory reaction, with the increased 
secretion of interleukin (IL)-1β and tumor necrosis factor (TNF)-α in ear tissue (IVETIĆ 
TKALČEVIĆ et al., in press). In the same report, azithromycin and clarithromycin exerted 
anti-infl ammatory effects by decreasing the concentration of Th1 cytokines. Similarly, 
several reports have shown that oral and transdermal macrolides inhibit immediate skin 
infl ammation, observed as ear and paw oedema, induced by different infl ammatory agents, 
such as croton oil, cantharidin, oxazolone, picryl chloride and carragenin (TARAYRE et al., 
1987; AGEN et al., 1993; SCAGLIONE and ROSSONI, 1998). However, in these experimental 
models, macrolides were administered as a preventive treatment before the infl ammation 
was induced. 
Since treatment with macrolides after infl ammation induction seems to be effective 
in oxazolone (OXA)-induced allergic skin infl ammatory reactions (IVETIĆ TKALČEVIĆ 
et al., in press), we aimed in this study to investigate whether the anti-infl ammatory 
effects of transdermally applied azithromycin and clarithromycin administered after 
infl ammation induction would also attenuate Th1-mediated PMA-induced immediate skin 
infl ammation, and to compare it to the effects of standard anti-infl ammatory corticosteroid 
dexamethasone.
Materials and methods
 Study design. PMA induction of immediate skin infl ammation was conducted 
according to IVETIĆ TKALČEVIĆ et al. (in press) with some modifi cations. Animals 
were anaesthetized by the inhalation of Isofl urane, delivered in an anaesthesia induction 
chamber (Stoelting Co., USA). Gas scavenging was provided using the Fluovac 240V 
system (International Market Supply, England). The fully anaesthetized animal was 
topically treated on the inner surface of both ears with 12 μL of 0.01% PMA solution in 
203Vet. arhiv 82 (2), 201-209, 2012
V. Ivetić Tkalčević and V. Eraković Haber: Attenuation of IL-1β secretion by macrolide post-infl ammatory 
treatment
acetone. Negative control animals were treated with the same volume of acetone. Thirty 
minutes after infl ammation induction, azithromycin (500 μg/15 μL/ear), clarithromycin 
(500 μg/15 μL/ear) and dexamethasone (50 μg/15 μL/ear) dissolved in a trans-phase 
delivery system (TPDS) (acetone : isopropanol : benzyl alcohol = 40% : 50% : 10%) were 
transdermally applied to the inner surface of both ears. The negative and positive controls 
were treated with the same volume of TPDS vehicle. Six hours after PMA administration, 
animals were anaesthetized as already described and, using a digital caliper (Mitutoyo 
IP63; type 209-530, Japan), connected to the measuring system Plexx (Netherlands) 
compound of the computer programme “Windows Hyper Terminal” and a pedal, the ear 
thickness of each animal was measured. In order to determine IL-1β concentration in ear 
tissue, the animals were then euthanized using intraperitoneal Thiopental injections, 8 
hours after infl ammation induction. Ear tissue was collected by cutting off both ears at the 
base. For the ELISA analysis, both ears of each animal were transferred into Eppendorf 
tubes and frozen at -20 °C. 
Animals. PMA-induced skin infl ammation was performed on male CD1 mice, 15 
weeks old, obtained from Charles River, France. Eight mice per group were kept on 
wire mesh fl oors with irradiated maize granulate bedding (Scobis Due, Mucedola, Italy) 
and maintained under standard laboratory conditions (temperature 23 - 24 °C, relative 
humidity 60 ± 5%, approx. 15 air changes per hour, artifi cial lighting with a circadian 
cycle of 12 h). Food (Standard food for mice and rats, 4R21, Mucedola, Italy) and tap 
water were provided ad libitum. Mice were allowed to acclimatize for 10 days before the 
beginning of each experiment. 
All procedures on the animals were performed in accordance with (a) the EEC Council 
Directive 86/609 of 24 November 1986 on the approximation of laws, regulations and 
administrative provisions of the Member States regarding the protection of animals used 
for experimental and other scientifi c purposes; and (b) the Constitution of the Republic 
Croatia, Animal Welfare Act, OG 135/06 of 13 December 2006.
Materials: drugs, chemicals and antibodies. Azithromycin was purchased from 
PLIVA Inc., Croatia, and clarithromycin and dexamethasone from Sigma Chemical Co., 
USA. PMA was obtained from Alexis biochemicals, USA. The inhalation anaesthetic 
Isofl ourane was purchased from Forane, Abbott Laboratories Ltd., UK while Thiopental 
used for the euthanasia of experimental animals was from Nycomed, Germany. Organic 
diluents (acetone, isopropanol and benzyl alcohol) were from Kemika, Croatia. IL-1β 
antibodies for enzyme-linked immunosorbent assay (ELISA) were from R&D Systems, 
USA. All other reagents were from Sigma Chemical Co., USA.
ELISA analysis. The concentration of IL-1β in ear tissue was determined by 
sandwich ELISA, using capture and detection antibodies, according to the manufacturer’s 
recommendations. Prior to analysis, both ears from the same animal were homogenized 
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in 1 mL of phosphate buffered saline (PBS), to which protease inhibitors were added 
(pepstatin A, phenylmethanesulfonyl fl uoride, leupeptin and aprotinin). The homogenate 
was centrifuged (10000 ×g) for 10 min at 4 °C. The resulting supernatant was then diluted 
10-fold. The fi nal concentrations were expressed as pg/mg of total protein in the ear tissue 
previously determined by biochemical analyzer (Olympus AU 400, UK).
Data analysis and statistical evaluation. Statistical analysis was conducted using 
GraphPad InStat v. 4.0 (GraphPad Software Inc., USA). A P-value <0.05 was regarded 
as signifi cant. For multiple comparisons, Kruskal-Wallis ANOVA with Dunn post-tests 
were used.
Results
Topically applied PMA induced ear swelling 6 hours after administration (Fig. 1). 
Treatment with azithromycin and clarithromycin at 500 μg/ear, and dexamethasone at 50 
μg/ear after infl ammation induction signifi cantly reduced ear thickness (Fig. 1). There 
was no marked difference in the anti-infl ammatory effects of the tested macrolides and 
dexamethasone.
Fig. 1. Ear thickness 6 hours after topical PMA administration. Dexamethasone, azithromycin 
and clarithromycin were applied transdermally 30 min after infl ammation induction. Data are 
presented as group averages ± SEM. The symbol * indicates signifi cant divergence from the 
positive control (P<0.05, Kruskal-Wallis ANOVA with Dunn post-tests, n = 8).
As previously reported (IVETIĆ TKALČEVIĆ et al., in press), the concentration of IL-
1β in ear tissue reaches its peak 8 hours after PMA application. Therefore the investigation 
of the effects of azithromycin, clarithromycin and dexamethasone on PMA-induced IL-
1β production was limited to that time frame. Like dexamethasone (50 μg/ear), both 
tested macrolides (500 μg/ear) applied 30 min after infl ammation induction signifi cantly 
reduced IL-1β concentration in ear tissue (Fig. 2).
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Fig. 2. Effects of dexamethasone, azithromycin and clarithromycin on interleukin (IL)-1β 
concentration in mouse ear tissue 8 hours after topical PMA administration. Substances were 
administered transdermally 30 min after infl ammation induction. Data are presented as group 
averages ± SEM. The symbol * indicates signifi cant divergence from positive control (P<0.05, 
Kruskal-Wallis ANOVA with Dunn post-tests, n = 8).
Discussion 
In this study of mouse PMA-induced immediate skin infl ammation, we initially 
confi rmed that PMA induces Th1 infl ammatory reaction. Like dexamethasone, 
transdermally applied macrolides, azithromycin and clarithromycin, inhibit acute 
infl ammatory responses, including ear swelling and IL-1β production, when administered 
after infl ammation induction.
Earlier investigations have indicated the anti-infl ammatory ability of commercially 
available macrolide antibiotics to attenuate ear and paw oedema induced by different 
infl ammatory agents when administered before infl ammation induction. TARAYRE et al. 
(1987) have shown that a single dose of transdermally applied erythromycin (0.250 - 1 mg/
ear) markedly decreases ear oedema induced by croton oil, cantharidin and picryl-chloride. 
In the experiment performed by AGEN et al. (1993) a single oral dose of roxithromycin at 5 
and 20 mg/kg signifi cantly reduced carrageenin and poly-L-arginin induced paw oedema 
and croton oil induced ear oedema. Also, SCAGLIONE and ROSSONI (1998) have indicated 
that a single oral pretreatment with roxithromycin, azithromycin and clarithromycin at 20 
mg/kg markedly inhibits carragenin induced paw oedema. 
Our group recently demonstrated the ability of standard macrolide antibiotics to 
attenuate allergic infl ammatory skin reactions when administered after induction. In 
contrast to the infl ammatory scheme, post-infl ammatory treatment with azithromycin 
and clarithromycin (both at 2 mg/ear) reduced infl ammatory cell accumulation and IL-4 
concentration in ear tissue in OXA-induced delayed type hypersensitivity (DTH) in mice 
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Although the mechanism of macrolide anti-infl ammatory activity remains unknown, 
the results from different in vivo models demonstrate that they inhibit Th1 mediated 
infl ammation by reducing the secretion of pro-infl ammatory cytokines such as IL-1β, 
interferon (IFN)-γ, TNF-α and granulocyte monocyte colony-stimulating factor (GM-
CSF) (IVETIĆ TKALČEVIĆ et al., 2006; 2008; BOSNAR et al., 2009).
The epicutaneous application of PMA results in vascular leakage, leukocyte 
infi ltration, epidermal hyperplasia, activation of protein kinase C and the increased 
release of arachidonic acid and its metabolites (YOUNG and DE YOUNG, 1989). In a mouse 
model of PMA-induced ear oedema, topically applied PMA induced the accumulation 
of predominantly polymorphonuclear (PMNL) and few mononuclear cells in ear tissue, 
which are the major sources of pro-infl ammatory Th1 cytokines IL-1β and TNF-α (IVETIĆ 
TKALČEVIĆ et al., in press). Macroscopically, infl ammation is observed as ear swelling. 
Since PMA induces a local skin infl ammatory reaction which, in terms of the accumulation 
of neutrophils, resembles psoriasis (DeYOUNG et al., 1989; FRETLAND et al., 1990), in 
our experiment azithromycin and clarithromycin were administered transdermally after 
infl ammation induction, in order to investigate whether macrolides applied during the 
treatment regimen described had anti-infl ammatory effects on such skin infl ammatory 
reactions. 
Administered before infl ammation induction, at 500 μg/ear, azithromycin and 
clarithromycin attenuated PMA-induced infl ammatory cell accumulation and thus 
decreased ear IL-1β and TNF-α concentration and ear swelling (IVETIĆ TKALČEVIĆ et 
al., in press). Since treatment with azithromycin and clarithromycin after infl ammation 
induction in our experiment reduced ear swelling and IL-1β concentration in ear tissue, 
and since accumulated PMNL cells are the cellular source of IL-1β (IVETIĆ TKALČEVIĆ 
et al., in press), it can be presumed that azithromycin and clarithromycin administered 
after infl ammation induction inhibited the accumulation of PMNL cells in ear tissue and 
thereby reduced IL-1β concentration, along with ear swelling. Interestingly, in comparison 
to the activity observed after the preventive treatment (IVETIĆ TKALČEVIĆ et al., in press), 
macrolide anti-infl ammatory treatment after inducing infl ammation was more similar to 
the effects of dexamethasone in terms of its activity on IL-1β secretion and ear swelling. 
This result is in accordance with previous observations made in an OXA-induced DTH 
model, in which azithromycin and clarithromycin demonstrated more potent anti-
infl ammatory activity on cellular accumulation and cytokine secretion when administered 
after an OXA challenge (IVETIĆ TKALČEVIĆ et al., in press). 
Conclusion
It can be concluded that, in addition to their effects on allergic skin reaction, the anti-
infl ammatory activity of commercially available macrolide antibiotics, administered after 
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the induction of infl ammatory reaction, also attenuates immediate skin infl ammation by 
inhibiting Th1-mediated infl ammatory processes. There is no signifi cant difference in 
the anti-infl ammatory activity of the tested doses of macrolides and dexamethasone after 
post-infl ammatory treatment in PMA-induced immediate skin infl ammation. This fi nding 
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SAŽETAK
Literaturni podaci pokazuju da odgovarajući makrolidni antibiotici, poput azitromicina i klaritromicina, 
osim protubakterijskih učinaka posjeduju i protuupalna i imunomodulacijska svojstva koja se očituju njihovim 
nakupljanjem u upalnim stanicama i sprječavanjem oslobađanja proupalnih citokina. Dosadašnja istraživanja 
pokazuju da davanje navedenih makrolida u miševa, prije izazivanja upale, umanjuje neposrednu upalnu 
reakciju kože. Međutim, njihova protuupalna svojstva nakon poslijeupalnog davanja u ovom pokusnom modelu 
nisu istražena. Cilj ovog istraživanja bio je istražiti da li azitromicin i klaritromicin, naneseni na površinu uške 
miševa 30 minuta nakon izazivanja neposredne upale kože s forbol 12-miristat 13-acetatom (PMA), svojim 
protuupalnim djelovanjem umanjuju Th1 upalni odgovor. Protuupalni učinci azitromicina i klaritromicina 
(500 μg / uški) bili su podjednaki protuupalnom djelovanju deksametazona (50 μg / uški), u smislu smanjenja 
otekline uške i koncentracije interleukina-1β u tkivu uške miševa obrađivanih s PMA-om, što ide u prilog 
klinički relevantnom načinu liječenja.
Ključne riječi: protuupalno djelovanje, IL-1β, makrolidni antibiotici, miš, upala kože ________________________________________________________________________________________
.
